1263 related articles for article (PubMed ID: 729822)
21. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
[TBL] [Abstract][Full Text] [Related]
22. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles.
Scott RT; Bailey SA; Kost ER; Neal GS; Hofmann GE; Illions EH
Fertil Steril; 1994 May; 61(5):872-9. PubMed ID: 8174724
[TBL] [Abstract][Full Text] [Related]
23. [Parameters of ovulation in clomiphene citrate treated cycles. The effect of pre-ovulatory administration of oestrogen and human chorionic gonadotropin].
van Schouwenburg JA
S Afr Med J; 1986 Feb; 69(4):237-40. PubMed ID: 3513342
[TBL] [Abstract][Full Text] [Related]
24. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
Yuen BH; Sy L; Cannon W
Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and biophysical indices of follicular development in spontaneous and stimulated ovulatory cycles.
Fossum GT; Vermesh M; Kletzky OA
Obstet Gynecol; 1990 Mar; 75(3 Pt 1):407-11. PubMed ID: 2106108
[TBL] [Abstract][Full Text] [Related]
26. Sequential use of clomiphene citrate and human menopausal gonadotropin in ovulation induction.
Kistner RW
Fertil Steril; 1976 Jan; 27(1):72-82. PubMed ID: 1245245
[TBL] [Abstract][Full Text] [Related]
27. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
Jones GE; Wentz AC; Rosenwaks Z; Shoemaker J
Am J Obstet Gynecol; 1977 Dec; 129(7):760-76. PubMed ID: 343592
[TBL] [Abstract][Full Text] [Related]
28. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
29. The mechanism of ovulation inhibition by triamcinolone acetonide.
Cunningham GR; Goldzieher JW; de la Pena A; Oliver M
J Clin Endocrinol Metab; 1978 Jan; 46(1):8-14. PubMed ID: 376542
[TBL] [Abstract][Full Text] [Related]
30. Plasma estrogen monitoring of ovulation induction.
Wu CH
Obstet Gynecol; 1975 Sep; 46(3):294-8. PubMed ID: 1172219
[TBL] [Abstract][Full Text] [Related]
31. Monitoring induction of ovulation with human menopausal gonadotropin by a rapid estrogen radioimmunoassay.
Tredway DR; Goebelsmann U; Thorneycroft IH; Mishell DR
Am J Obstet Gynecol; 1974 Dec; 120(8):1035-40. PubMed ID: 4473896
[TBL] [Abstract][Full Text] [Related]
32. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
Cameron ST; Thong KJ; Baird DT
Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
[TBL] [Abstract][Full Text] [Related]
33. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
Lemay A; Faure N
J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
[TBL] [Abstract][Full Text] [Related]
34. Levels of luteinizing hormone (LH), follicle-stimulating hormone, and 17 beta-estradiol in response to D-Trp6-LH-releasing hormone during different phases of the menstrual cycle in normal women.
Jaramillo CJ; Salgado AC; Perez-Infante V; Puente-Cueva M; Botella-Llusia J; Coy DH; Schally A
Fertil Steril; 1978 Feb; 29(2):153-8. PubMed ID: 342285
[TBL] [Abstract][Full Text] [Related]
35. Hormonal changes related to impairment of cervical mucus in cycles stimulated by clomiphene citrate.
Langer R; Golan A; Ron-el R; Pansky M; Neuman M; Caspi E
Aust N Z J Obstet Gynaecol; 1990 Aug; 30(3):254-6. PubMed ID: 2124104
[TBL] [Abstract][Full Text] [Related]
36. Plasma gastrointestinal hormones during spontaneous and induced menstrual cycles.
Holst N; Jenssen TG; Burhol PG; Haug E; Forsdahl F
J Clin Endocrinol Metab; 1989 Jun; 68(6):1160-6. PubMed ID: 2498386
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
[TBL] [Abstract][Full Text] [Related]
38. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
[TBL] [Abstract][Full Text] [Related]
39. Leukocyte alkaline phosphatase monitoring of ovarian function in normal and clomiphene-treated cycles.
Polishuk WZ; Diamant YZ
Fertil Steril; 1973 Apr; 24(4):245-51. PubMed ID: 4694500
[TBL] [Abstract][Full Text] [Related]
40. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
